- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00279981
TRENDS: A Prospective Study of the Clinical Significance of Atrial Arrhythmias Detected by Implanted Device Diagnostics
10. december 2008 opdateret af: Medtronic Cardiac Rhythm and Heart Failure
The purpose of this study is to look at the heart rate and rhythm information collected daily in Medtronic implantable pulse generators (IPG), implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy (CRT) devices.
The study will gather this information from many patients to see if heart rate or rhythm data can predict the risk of a patient having a medical condition such as stroke.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Observationel
Tilmelding
3100
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Perth-Western Australia, Australien
-
-
New South Wales
-
Liverpool, New South Wales, Australien
-
New Lambton, New South Wales, Australien
-
-
South Australia
-
Bedford Park, South Australia, Australien
-
-
-
-
Alberta
-
Calgary, Alberta, Canada
-
-
Ontario
-
London, Ontario, Canada
-
-
-
-
Arizona
-
Mesa, Arizona, Forenede Stater
-
Tucson, Arizona, Forenede Stater
-
-
California
-
Fountain Valley, California, Forenede Stater
-
Mission Viejo, California, Forenede Stater
-
Modesto, California, Forenede Stater
-
National City, California, Forenede Stater
-
Palm Springs, California, Forenede Stater
-
Salinas, California, Forenede Stater
-
San Bernadino, California, Forenede Stater
-
Torrance, California, Forenede Stater
-
-
Connecticut
-
Norwalk, Connecticut, Forenede Stater
-
-
Delaware
-
Newark, Delaware, Forenede Stater
-
-
District of Columbia
-
Washington, District of Columbia, Forenede Stater
-
-
Florida
-
Ft. Lauderdale,, Florida, Forenede Stater
-
Hollywood, Florida, Forenede Stater
-
Melbourne, Florida, Forenede Stater
-
Naples, Florida, Forenede Stater
-
Palm Beach Gardens, Florida, Forenede Stater
-
St. Petersburg, Florida, Forenede Stater
-
-
Georgia
-
Atlanta, Georgia, Forenede Stater
-
-
Idaho
-
Boise, Idaho, Forenede Stater
-
-
Illinois
-
Chicago, Illinois, Forenede Stater
-
-
Indiana
-
Indianapolis, Indiana, Forenede Stater
-
Munster, Indiana, Forenede Stater
-
-
Iowa
-
Ames, Iowa, Forenede Stater
-
-
Kansas
-
Wichita, Kansas, Forenede Stater
-
-
Kentucky
-
Ashland, Kentucky, Forenede Stater
-
Lexington, Kentucky, Forenede Stater
-
-
Louisiana
-
Covington, Louisiana, Forenede Stater
-
Slidell, Louisiana, Forenede Stater
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater
-
Hagerstown, Maryland, Forenede Stater
-
Takoma Park, Maryland, Forenede Stater
-
-
Massachusetts
-
Boston, Massachusetts, Forenede Stater
-
Brighton, Massachusetts, Forenede Stater
-
Burlington, Massachusetts, Forenede Stater
-
Worcester, Massachusetts, Forenede Stater
-
-
Michigan
-
Grand Blanc, Michigan, Forenede Stater
-
Kalamazoo, Michigan, Forenede Stater
-
Mt. Clemens, Michigan, Forenede Stater
-
Saginaw, Michigan, Forenede Stater
-
-
Minnesota
-
Duluth, Minnesota, Forenede Stater
-
Minneapolis, Minnesota, Forenede Stater
-
St. Paul,, Minnesota, Forenede Stater
-
-
Mississippi
-
Gulfport, Mississippi, Forenede Stater
-
Hattiesburg, Mississippi, Forenede Stater
-
Tupelo, Mississippi, Forenede Stater
-
-
Missouri
-
St. Louis, Missouri, Forenede Stater
-
-
Nebraska
-
Lincoln, Nebraska, Forenede Stater
-
Omaha, Nebraska, Forenede Stater
-
-
New Hampshire
-
Lebanon, New Hampshire, Forenede Stater
-
-
New Jersey
-
Camden, New Jersey, Forenede Stater
-
Cherry Hill, New Jersey, Forenede Stater
-
Hackensack, New Jersey, Forenede Stater
-
Haddon Heights, New Jersey, Forenede Stater
-
West Orange, New Jersey, Forenede Stater
-
-
New York
-
Brooklyn, New York, Forenede Stater
-
New York, New York, Forenede Stater
-
Poughkeepsie, New York, Forenede Stater
-
Syracuse, New York, Forenede Stater
-
-
North Carolina
-
Greensboro, North Carolina, Forenede Stater
-
Pinehurst, North Carolina, Forenede Stater
-
Raleigh, North Carolina, Forenede Stater
-
Winston-Salem, North Carolina, Forenede Stater
-
Winston-Salem,, North Carolina, Forenede Stater
-
-
Ohio
-
Cleveland, Ohio, Forenede Stater
-
Columbus, Ohio, Forenede Stater
-
Fairview Park, Ohio, Forenede Stater
-
Marion, Ohio, Forenede Stater
-
Toledo, Ohio, Forenede Stater
-
-
Oklahoma
-
Midwest City, Oklahoma, Forenede Stater
-
-
Pennsylvania
-
Easton, Pennsylvania, Forenede Stater
-
Philadelphia, Pennsylvania, Forenede Stater
-
-
South Carolina
-
Charleston, South Carolina, Forenede Stater
-
Columbia, South Carolina, Forenede Stater
-
Greenville, South Carolina, Forenede Stater
-
-
Tennessee
-
Chattanooga, Tennessee, Forenede Stater
-
Knoxville, Tennessee, Forenede Stater
-
Memphis, Tennessee, Forenede Stater
-
Nashville, Tennessee, Forenede Stater
-
-
Texas
-
Austin, Texas, Forenede Stater
-
Austin,, Texas, Forenede Stater
-
Corpus Christi, Texas, Forenede Stater
-
Dallas, Texas, Forenede Stater
-
Ft. Worth, Texas, Forenede Stater
-
Houston, Texas, Forenede Stater
-
Odessa, Texas, Forenede Stater
-
Tyler, Texas, Forenede Stater
-
-
Virginia
-
Charlottesville, Virginia, Forenede Stater
-
Norfolk, Virginia, Forenede Stater
-
Richmond, Virginia, Forenede Stater
-
-
Washington
-
Spokane, Washington, Forenede Stater
-
-
Wisconsin
-
La Crosse, Wisconsin, Forenede Stater
-
Milwaukee, Wisconsin, Forenede Stater
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Subject provides written informed consent and privacy/protection authorization.
- Subjects 65 years of age or older.
OR
- Subjects with age >18 and < 65 years and one of the following stroke risk factors:
- Prior stroke or TIA
- Diagnosis of hypertension (HTN)
- Diagnosis of Diabetes Mellitus (DM)
- Diagnosis of Congestive Heart Failure (CHF)
- Subjects who meet the Class I/Class II indications for a dual chamber implantable pulse generator or dual chamber implanted cardioverter defibrillator device
OR
• Subjects who meet the criteria for indication of a dual chamber resynchronization device with bi-ventricular pacing (moderate to severe CHF symptoms [NYHA Class III-IV] despite optimal medical therapy, left ventricular ejection fraction ≤ 35%, and a QRS duration ≥130 ms)13.
Exclusion Criteria:
- Subjects who are to receive a replacement IPG, ICD or CRT device.
- Subjects with chronic (permanent) AT/AF.
- Subjects with a history of AV nodal dependent arrhythmias.
- Subjects with a terminal illness who are not expected to survive more than 6 months.
- Subjects who are unwilling or unable to cooperate or give written informed consent and privacy/protection authorization, or subjects whose legal representatives or legal guardians refuse to give informed consent or privacy/protection authorization.
- Subjects currently receiving treatment in another drug and/or device study which could affect the outcome of the trial.
- Subjects who are or will be inaccessible for follow-up at a qualified study center.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Emile Daoud, MD, Riverside Hospital
- Ledende efterforsker: Taya Glotzer, MD, Hackensack Meridian Health
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Generelle publikationer
- Yano Y, Greenland P, Lloyd-Jones DM, Daoud EG, Koehler JL, Ziegler PD. Simulation of Daily Snapshot Rhythm Monitoring to Identify Atrial Fibrillation in Continuously Monitored Patients with Stroke Risk Factors. PLoS One. 2016 Feb 16;11(2):e0148914. doi: 10.1371/journal.pone.0148914. eCollection 2016.
- Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C, Miller C, Qi D, Ziegler PD. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol. 2009 Oct;2(5):474-80. doi: 10.1161/CIRCEP.109.849638. Epub 2009 Aug 4.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. november 2003
Primær færdiggørelse (Faktiske)
1. juni 2007
Studieafslutning (Faktiske)
1. juni 2007
Datoer for studieregistrering
Først indsendt
18. januar 2006
Først indsendt, der opfyldte QC-kriterier
18. januar 2006
Først opslået (Skøn)
20. januar 2006
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
11. december 2008
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
10. december 2008
Sidst verificeret
1. december 2008
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 219
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Hjertefejl
-
Region SkaneTilmelding efter invitationHjertesvigt New York Heart Association (NYHA) klasse II | Hjertesvigt New York Heart Association (NYHA) klasse IIISverige
-
Medical University of BialystokInstitute of Cardiology, Warsaw, Poland; Medical University of Lodz; Poznan... og andre samarbejdspartnereIkke rekrutterer endnuHjertesvigt, systolisk | Hjertesvigt med reduceret udstødningsfraktion | Hjertesvigt New York Heart Association Klasse IV | Hjertesvigt New York Heart Association Klasse IIIPolen
-
University of WashingtonAmerican Heart AssociationAfsluttetHjertesvigt, Kongestiv | Mitokondriel ændring | Hjertesvigt New York Heart Association Klasse IVForenede Stater
-
Novartis PharmaceuticalsAfsluttetPatienter, der med succes afslutter den 12-måneders behandlingsperiode i kernestudiet (de Novo Heart-modtagere), som var interesserede i at blive behandlet med EC-MPS
-
University Hospital, GasthuisbergUkendtTransient Left Ventricular Ballooning SyndromeBelgien
-
NYU Langone HealthRekrutteringTako-tsubo kardiomyopati | Takotsubo kardiomyopati | Broken Heart SyndromeForenede Stater
-
French Cardiology SocietyAfsluttet
Kliniske forsøg med Diagnostic
-
Bausch & Lomb IncorporatedAfsluttet
-
University Hospital TuebingenAfsluttetSjældne sygdomme | Genetisk dispositionTyskland
-
Sun Yat-sen UniversityUkendt
-
Henry M. Jackson Foundation for the Advancement...The Citadel, The Military College of North CarolinaUkendtTraumatisk hjerneskade | Post traumatisk stress syndromForenede Stater
-
University of MichiganNational Institute on Aging (NIA)Tilmelding efter invitationAlzheimers sygdom | Mild kognitiv svækkelse | Amnestisk mild kognitiv lidelseForenede Stater
-
University Hospital TuebingenRekrutteringGenetisk disposition for sygdom | Sjældne sygdommeTyskland
-
PATHIkke rekrutterer endnuPrimære immundefektsygdommePakistan
-
IdentigeneCRI Lifetree Clinical ResearchUkendt
-
Prometheus Biosciences, Inc., a subsidiary of Merck...Aktiv, ikke rekrutterendeColitis ulcerosaForenede Stater, Australien, Belgien, Tjekkiet, Frankrig, Georgien, Canada, Ungarn, Israel, Italien, Polen, Det Forenede Kongerige
-
Abbott Rapid DxBill and Melinda Gates FoundationAfsluttet